Concepedia

Valentina Goldfinger

VG

Statistics

Publications

5

Citations

286

H-Index

5

Active since

2012

Affiliations

Immatics Biotechnologies (Germany)(Current)

Imec the Netherlands

University of Tübingen

Valentina Goldfinger is an author at Immatics Biotechnologies (Germany) specializing in life sciences, cancer immunology, and tumor immunology.

ORCID

Publications per year

2012–2023

5

Publications

5

RNA editing derived epitopes function as cancer antigens to elicit immune responses

Minying Zhang, Jens Fritsche, Jason Roszik et al. · Nature Communications · 2018 · 154 citations · Full text

, , +17

Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection

Jens Fritsche, Barbara Rakitsch, Franziska Hoffgaard et al. · PROTEOMICS · 2018 · 42 citations · Full text

, , +17

Quantitative immunopeptidomics reveals a tumor stroma–specific target for T cell therapy

Gloria B. Kim, Jens Fritsche, Sebastian Bunk et al. · Science Translational Medicine · 2022 · 40 citations · Full text

, , +17

Wunen, a <i>Drosophila</i> lipid phosphate phosphatase, is required for septate junction-mediated barrier function

Kristina E. Ile, Ratna Tripathy, Valentina Goldfinger et al. · Development · 2012 · 38 citations · Full text

, , +12

Metabolic engineering of the shikimate pathway in Amycolatopsis strains for optimized glycopeptide antibiotic production

Valentina Goldfinger, Marius Spohn, Jens-Peter Rodler et al. · Metabolic Engineering · 2023 · 12 citations

, , +14

1–5 of 5